145 related articles for article (PubMed ID: 10914946)
1. A homozygosity state for 20210A prothrombin variant in a young woman as cause of a deep venous thrombosis during pregnancy.
Acquila M; Bicocchi MP; Mori PG; Odino S; Valetto A; Bottini F
Eur J Haematol; 2000 Jul; 65(1):80-1. PubMed ID: 10914946
[No Abstract] [Full Text] [Related]
2. Homozygous G20210A transition in the prothrombin gene associated with severe venous thrombotic disease: two cases in a French family.
Zawadzki C; Gaveriaux V; Trillot N; Bauters A; Watel A; Alhenc-Gelas M; Preudhomme C; Jude B
Thromb Haemost; 1998 Dec; 80(6):1027-8. PubMed ID: 9869179
[No Abstract] [Full Text] [Related]
3. Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos.
Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ramírez-Cisneros FJ
Am J Hematol; 2001 Jan; 66(1):28-31. PubMed ID: 11426488
[TBL] [Abstract][Full Text] [Related]
4. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults.
Voetsch B; Damasceno BP; Camargo EC; Massaro A; Bacheschi LA; Scaff M; Annichino-Bizzacchi JM; Arruda VR
Thromb Haemost; 2000 Feb; 83(2):229-33. PubMed ID: 10739378
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism in a young woman with combined homozygosity for factor V Leiden and prothrombin G20210A mutations.
Leonard M; Gala JL; Verschuren F; Coche E; Deneys V; Hainaut P
Haematologica; 2005 Nov; 90 Suppl():ECR30. PubMed ID: 16266921
[No Abstract] [Full Text] [Related]
6. Inherited thrombophilia genes in minorities.
Mack R; Chowdary D; Streck D; Dermody J
Genet Test; 1999; 3(4):371-3. PubMed ID: 10627946
[TBL] [Abstract][Full Text] [Related]
7. Thrombosis-associated gene variants in sickle cell anemia.
Romana M; Muralitharan S; Ramasawmy R; Nagel RL; Krishnamoorthy R
Thromb Haemost; 2002 Feb; 87(2):356-8. PubMed ID: 11858507
[No Abstract] [Full Text] [Related]
8. Prevalence of genetic mutations that predispose to thrombophilia in a Greek Cypriot population.
Angelopoulou K; Nicolaides A; Constantinou Deltas C
Clin Appl Thromb Hemost; 2000 Apr; 6(2):104-7. PubMed ID: 10775032
[TBL] [Abstract][Full Text] [Related]
9. Sudden infant death syndrome, childhood thrombosis, and presence of genetic risk factors for thrombosis.
Larsen TB; Nørgaard-Pedersen B; Lundemose JB; Rüdiger N; Gaustadnes M; Brandslund I
Thromb Res; 2000 May; 98(4):233-9. PubMed ID: 10822069
[TBL] [Abstract][Full Text] [Related]
10. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.
Domagala TB; Adamek L; Nizankowska E; Sanak M; Szczeklik A
Blood Coagul Fibrinolysis; 2002 Jul; 13(5):423-31. PubMed ID: 12138370
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of two genetic traits related to venous thrombosis in whites and African-Americans.
Austin H; Hooper WC; Dilley A; Drews C; Renshaw M; Ellingsen D; Evatt B
Thromb Res; 1997 Jun; 86(5):409-15. PubMed ID: 9211632
[No Abstract] [Full Text] [Related]
12. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review.
Morrison ER; Miedzybrodzka ZH; Campbell DM; Haites NE; Wilson BJ; Watson MS; Greaves M; Vickers MA
Thromb Haemost; 2002 May; 87(5):779-85. PubMed ID: 12038776
[TBL] [Abstract][Full Text] [Related]
13. Application of the TaqMan-PCR for genotyping of the prothrombin G20210A mutation and of the thermolabile methylenetetrahydrofolate reductase mutation.
Happich D; Madlener K; Schwaab R; Hanfland P; Pötzsch B
Thromb Haemost; 2000 Jul; 84(1):144-5. PubMed ID: 10928490
[No Abstract] [Full Text] [Related]
14. Prevalence of three prothrombotic polymorphisms. Factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase (MTHFR) C 677T in Argentina. On behalf of the Grupo Cooperativo Argentino de Hemostasia y Trombosis.
Genoud V; Castañon M; Annichino-Bizzacchi J; Korin J; Kordich L
Thromb Res; 2000 Nov; 100(3):127-31. PubMed ID: 11108898
[No Abstract] [Full Text] [Related]
15. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
[TBL] [Abstract][Full Text] [Related]
16. Effect of the MTHFRC677T variant on risk of venous thromboembolism: interaction with factor V Leiden and prothrombin (F2G20210A) mutations.
Brown K; Luddington R; Baglin T
Br J Haematol; 1998 Oct; 103(1):42-4. PubMed ID: 9792287
[TBL] [Abstract][Full Text] [Related]
17. A boy with venous thrombosis, homozygous for factor V Leiden, prothrombin G20210A and MTHFR C667t mutations, but belonging to an asymptomatic family.
Soria JM; Quintana R; Vallvé C; Iruin G; Cortés C; Fontcuberta J
Haematologica; 2000 Nov; 85(11):1230-2. PubMed ID: 11064483
[No Abstract] [Full Text] [Related]
18. Thrombophilic mutations impart a high risk of pregnancy-related venous thrombosis.
Press RD
Mol Diagn; 2000 Jun; 5(2):158. PubMed ID: 11066018
[No Abstract] [Full Text] [Related]
19. Factor V Leiden--the commonest molecular defect in arterial and venous thrombophilia in India.
Ahmed RP; Gupta PK; Kannan M; Choudhry VP; Saxena R
Thromb Res; 2003 Apr; 110(1):19-21. PubMed ID: 12877904
[No Abstract] [Full Text] [Related]
20. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.
De Stefano V; Casorelli I; Rossi E; Zappacosta B; Leone G
Semin Thromb Hemost; 2000; 26(3):305-11. PubMed ID: 11011848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
